» Articles » PMID: 32546668

Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma

Overview
Journal mSystems
Specialty Microbiology
Date 2020 Jun 18
PMID 32546668
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors influencing progression from cirrhosis to HCC remain largely unknown. Gut microbiota plays a key role in liver diseases; however, its association with HCC remains elusive. This study aimed to elucidate microbial differences between patients with HCC-associated cirrhosis (HCC-cirrhosis) and cirrhotic patients without HCC and healthy volunteers and to explore the associations between diet, lifestyle, and the microbiome of these patients. Fecal samples and food frequency questionnaires were collected from 95 individuals (30 HCC-cirrhosis patients, 38 cirrhotic patients without HCC, and 27 age- and body mass index [BMI]-matched healthy volunteers). 16S rRNA gene sequencing was performed. Bacterial richness in cirrhosis and HCC-cirrhosis patients was significantly lower than in healthy controls. The HCC-cirrhosis group was successfully classified with an area under the curve (AUC) value of 0.9 based on the dysbiotic fecal microbial signature. The HCC-cirrhosis group had a significant overrepresentation of and and reduced abundance compared to cirrhotic patients without HCC. Patients with HCC-cirrhosis who were overweight displayed significantly decreased bacterial richness and altered microbiota composition compared to their normal-weight counterparts. There was a significant correlation in the HCC-cirrhosis group between intake of artificial sweeteners and the presence of A unique microbial signature was observed in patients with HCC-cirrhosis, irrespective of cirrhosis stage, diet, or treatment. BMI, dietary sugar, and artificial sweeteners were significantly associated with alterations in the microbiome of HCC-cirrhosis patients. However, the increased abundance of and observed in HCC-cirrhosis patients was not influenced by environmental factors, implying that this change was due to development of HCC. Development of hepatocellular carcinoma in patients with cirrhosis is associated with alterations in intestinal microbiota, including an escalation of dysbiosis and reduced bacterial richness. This study demonstrates that reduced bacterial richness and dysbiosis escalate with the progression of cirrhosis from compensated to decompensated cirrhosis and to HCC-associated cirrhosis (HCC-cirrhosis). Moreover, we report for the first time the effect of environmental factors on HCC-cirrhosis. Excess weight was associated with increased dysbiosis in patients with HCC compared to their normal-weight counterparts. Moreover, fatty liver, consumption of artificial sweeteners, and high-sugar foods were associated with altered microbial composition, including altered levels of in HCC-cirrhosis. We have successfully determined that levels of and the two genera and are significantly altered in cirrhotic patients who develop hepatocellular carcinoma, independently of cirrhosis severity and dietary habits.

Citing Articles

A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition.

Xirouchakis E, Pelekanos A, Xirouchakis S, Kranidioti H, Manolakopoulos S Int J Mol Sci. 2025; 26(2).

PMID: 39859243 PMC: 11765289. DOI: 10.3390/ijms26020527.


Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis.

Liu Y, Chen Z, Li C, Sun T, Luo X, Jiang B BMC Gastroenterol. 2025; 25(1):16.

PMID: 39806278 PMC: 11727502. DOI: 10.1186/s12876-025-03589-5.


Novel Biomarkers for Early Detection of Hepatocellular Carcinoma.

Attia A, Rezaee-Zavareh M, Hwang S, Kim N, Adetyan H, Yalda T Diagnostics (Basel). 2024; 14(20).

PMID: 39451600 PMC: 11507329. DOI: 10.3390/diagnostics14202278.


Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers.

Pallozzi M, De Gaetano V, Di Tommaso N, Cerrito L, Santopaolo F, Stella L Nutrients. 2024; 16(14).

PMID: 39064815 PMC: 11280141. DOI: 10.3390/nu16142372.


Interaction between Per- and Polyfluorinated Substances (PFAS) and Acetaminophen in Disease Exacerbation-Focusing on Autism and the Gut-Liver-Brain Axis.

Jiang D, Guo T Toxics. 2024; 12(1).

PMID: 38250995 PMC: 10818890. DOI: 10.3390/toxics12010039.


References
1.
Amir A, McDonald D, Navas-Molina J, Kopylova E, Morton J, Xu Z . Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns. mSystems. 2017; 2(2). PMC: 5340863. DOI: 10.1128/mSystems.00191-16. View

2.
Yun Y, Kim H, Kim S, Heo S, Chang Y, Ryu S . Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort. BMC Microbiol. 2017; 17(1):151. PMC: 5497371. DOI: 10.1186/s12866-017-1052-0. View

3.
Marrero J, Kulik L, Sirlin C, Zhu A, Finn R, Abecassis M . Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018; 68(2):723-750. DOI: 10.1002/hep.29913. View

4.
Caporaso J, Lauber C, Walters W, Berg-Lyons D, Huntley J, Fierer N . Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012; 6(8):1621-4. PMC: 3400413. DOI: 10.1038/ismej.2012.8. View

5.
McDonald D, Price M, Goodrich J, Nawrocki E, DeSantis T, Probst A . An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2011; 6(3):610-8. PMC: 3280142. DOI: 10.1038/ismej.2011.139. View